Hi fellows, My cancer was diagnosed as Gleason 9 and non-metastatic. It's been treated in recent months with EBRT and brachytherapy. I'm on Casodex & Lupron, and the Lupron will continue into 2020. But I feel maybe I could be doing more. Sometimes I'll read on the message boards that someone who seems to be in my situation is taking Zytiga, though Zytiga is associated with metastatic PCa (or in some cases, castration-resistant non-metastatic PCa). I asked my doctor about my taking Zytiga, but it's too non-standard for him. Does anyone have experience with, or information about, taking Zytiga in a case like mine? Thanks a lot.
Zytiga for high-risk non-metastatic P... - Advanced Prostate...
Zytiga for high-risk non-metastatic PCa?
If you use all the bullets now, you may wish you saved some for later...I'm not sure Zytiga is approved for non-met PC. If it's not, your insurance company will never pay for it..What is your PSA now ?
It is non-standard to add Zytiga - it might help or it might just add to side effects. In fact, it is questIonable whether ADT is needed at all with brachy boost therapy. Is the Lupron keeping your T levels low?
Wow, Allen! Questionable about ADT with brachy boost in the first place! My doctor still hasn't tested me for T, or PSA, and doesn't plan to until 3 months after brachytherapy. Anyway, THANKS as always for writing.
TA
On a related subject , if my T is down to <3.0 on trelstar alone I don’t see any need to go back on bicalutamide and/or avodart or add Zytiga, do you? Psa is declining again after doubling every two months.
Bob
"Standard of care" was the exact phrase used by my doctor. That's interesting and telling about the Batman trial. I do crave the info/knowledge. You've been a source of both here on HealthUnlocked.